Role of IL-17A on resolution of pulmonary C. neoformans infection

PLoS ONE

Volumn 6, Issue 2, 2011, Pages

  Wozniak, Karen L ^a   Hardison, Sarah E ^a   Kolls, Jay K ^b   Wormley Jr , Floyd L ^a  

^a UNIVERSITY OF TEXAS AT SAN ANTONIO   (United States)

^b LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON RECEPTOR; INTERLEUKIN 17; INTERLEUKIN 17 RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CRYPTOCOCCUS NEOFORMANS; CYTOKINE PRODUCTION; FEMALE; FUNGAL STRAIN; GENE DELETION; IMMUNE RESPONSE; MOUSE; NEUTROPHIL; NONHUMAN; PROTEIN FUNCTION; PROTEIN INDUCTION; PULMONARY CRYPTOCOCCOSIS; SIGNAL TRANSDUCTION; T LYMPHOCYTE; TH1 CELL; TH17 CELL; WILD TYPE; ANIMAL; BAGG ALBINO MOUSE; CELL PROTECTION; CELLULAR IMMUNITY; CRYPTOCOCCOSIS; GENETICS; IMMUNOLOGY; LUNG; LUNG MYCOSIS; METABOLISM; MORTALITY; MOUSE MUTANT; NEUTROPHIL CHEMOTAXIS; PATHOLOGY; PHYSIOLOGY;

MUS;

ANIMALS; CHEMOTAXIS, LEUKOCYTE; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; CYTOPROTECTION; FEMALE; IMMUNITY, CELLULAR; INTERLEUKIN-17; LUNG; LUNG DISEASES, FUNGAL; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; TH1 CELLS; TH17 CELLS;

EID: 79951970813     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0017204     Document Type: Article

References (54)

1. Levitz SM, (1991) The ecology of Cryptococcus neoformans and the epidemiology of cryptococcosis. Rev Infect Dis 13: 1163-1169.
2. Mitchell TG, Perfect JR, (1995) Cryptococcosis in the Era of AIDS- 100 years after the discovery of Cryptococcus neoformans. Clin Microbiol Rev 8: 515-548.
3. Shoham S, Levitz SM, (2005) The immune response to fungal infections. Br J Haematol 129: 569-582.
4. Singh N, Gayowski T, Wagener MM, Marino IR, (1997) Clinical spectrum of invasive cryptococcosis in liver transplant recipients receiving tacrolimus. Clin Transplant 11: 66-70.
5. Singh N, Dromer F, Perfect JR, Lortholary O, (2008) Cryptococcosis in solid organ transplant recipients: current state of the science. Clin Infect Dis 47: 1321-1327.
6. Hill JO, Harmsen AG, (1991) Intrapulmonary growth and dissemination of an avirulent strain of Cryptococcus neoformans in mice depleted of CD4+ or CD8+ T-Cells. J Exp Med 173: 755-758.
7. Huffnagle GB, Lipscomb MF, Lovchik JA, Hoag KA, Street NE, (1994) The role of CD4(+) and CD8(+) T-Cells in the protective inflammatory response to a pulmonary cryptococcal infection. J Leukoc Biol 55: 35-42.
8. Huffnagle GB, Yates JL, Lipscomb MF, (1991) Immunity to a pulmonary Cryptococcus neoformans infection requires both CD4+ and CD8+ T-Cells. J Exp Med 173: 793-800.
9. Huffnagle GB, Yates JL, Lipscomb MF, (1991) T-cell-mediated immunity in the lung- a Cryptococcus neoformans pulmonary infection model using SCID and athymic nude-mice. Infect Immun 59: 1423-1433.
10. Mody CH, Lipscomb MF, Street NE, Toews GB, (1990) Depletion of CD4+ (L3T4+) lymphocytes in vivo impairs murine host defense to Cryptococcus neoformans. J Immunol 144: 1472-1477.
11. Chuck SL, Sande MA, (1989) Infections with Cryptococcus neoformans in the Acquired Immunodeficiency Syndrome. New Engl J Med 321: 794-799.
12. Blasi E, Mazzolla R, Barluzzi R, Mosci P, Bistoni F, (1994) Anticryptococcal resistance in the mouse brain: beneficial effects of local administration of heat-inactivated yeast cells. Infect Immun 62: 3189-3196.
13. Buchanan KL, Doyle HA, (2000) Requirement for CD4+ T Lymphocytes in Host Resistance against Cryptococcus neoformans in the Central Nervous System of Immunized Mice. Infect Immun 68: 456-462.
14. Wormley FL Jr, Perfect JR, Steele C, Cox GM, (2007) Protection Against Cryptococcosis using a Murine Interferon-gamma Producing Cryptococcus neoformans Strain. Infect Immun 75: 1453-1462.
15. Young M, Macias S, Thomas D, Wormley FL Jr, (2009) A proteomic-based approach for the identification of immunodominant Cryptococcus neoformans proteins. Proteomics 9: 2578-2588.
16. Wozniak KL, Ravi S, Macias S, Young ML, Olszewski MA, et al. (2009) Insights into the mechanisms of protective immunity against Cryptococcus neoformans infection using a mouse model of pulmonary cryptococcosis. PLoS ONE 4: e6854.
17. Kleinschek MA, Muller U, Brodie SJ, Stenzel W, Kohler G, et al. (2006) IL-23 Enhances the Inflammatory Cell Response in Cryptococcus neoformans Infection and Induces a Cytokine Pattern Distinct from IL-12. J Immunol 176: 1098-1106.
18. Mills KH, (2008) Induction, function and regulation of IL-17-producing T cells. Eur J Immunol 38: 2636-2649.
19. Peck A, Mellins ED, (2010) Precarious balance: Th17 cells in host defense. Infect Immun 78: 32-38.
20. Korn T, Bettelli E, Oukka M, Kuchroo VK, (2009) IL-17 and Th17 Cells. Annu Rev Immunol 27: 485-517.
21. Ley K, Smith E, Stark MA, (2006) IL-17A-producing neutrophil-regulatory Tn lymphocytes. Immunol Res 34: 229-242.
22. Ferretti S, Bonneau O, Dubois GR, Jones CE, Trifilieff A, (2003) IL-17, produced by lymphocytes and neutrophils, is necessary for lipopolysaccharide-induced airway neutrophilia: IL-15 as a possible trigger. J Immunol 170: 2106-2112.
23. Smith E, Stark MA, Zarbock A, Burcin TL, Bruce AC, et al. (2008) IL-17A inhibits the expansion of IL-17A-producing T cells in mice through "short-loop" inhibition via IL-17 receptor. J Immunol 181: 1357-1364.
24. Song C, Luo L, Lei Z, Li B, Liang Z, et al. (2008) IL-17-producing alveolar macrophages mediate allergic lung inflammation related to asthma. J Immunol 181: 6117-6124.
25. Kish DD, Li X, Fairchild RL, (2009) CD8 T cells producing IL-17 and IFN-gamma initiate the innate immune response required for responses to antigen skin challenge. J Immunol 182: 5949-5959.
26. Nembrini C, Marsland BJ, Kopf M, (2009) IL-17-producing T cells in lung immunity and inflammation. J Allergy Clin Immunol 123: 986-994; quiz 995-986.
27. Braun RK, Ferrick C, Neubauer P, Sjoding M, Sterner-Kock A, et al. (2008) IL-17 producing gammadelta T cells are required for a controlled inflammatory response after bleomycin-induced lung injury. Inflammation 31: 167-179.
28. Romani L, Zelante T, De Luca A, Fallarino F, Puccetti P, (2008) IL-17 and therapeutic kynurenines in pathogenic inflammation to fungi. J Immunol 180: 5157-5162.
29. Korn T, Bettelli E, Gao W, Awasthi A, Jager A, et al. (2007) IL-21 initiates an alternative pathway to induce proinflammatory T(H)17 cells. Nature 448: 484-487.
30. Bettelli E, Carrier Y, Gao W, Korn T, Strom TB, et al. (2006) Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441: 235-238.
31. Linden A, Laan M, Anderson GP, (2005) Neutrophils, interleukin-17A and lung disease. Eur Respir J 25: 159-172.
32. Witowski J, Pawlaczyk K, Breborowicz A, Scheuren A, Kuzlan-Pawlaczyk M, et al. (2000) IL-17 Stimulates Intraperitoneal Neutrophil Infiltration Through the Release of GRO{alpha} Chemokine from Mesothelial Cells. J Immunol 165: 5814-5821.
33. Chung DR, Kasper DL, Panzo RJ, Chtinis T, Grusby MJ, et al. (2003) CD4+ T Cells Mediate Abscess Formation in Intra-abdominal Sepsis by an IL-17-Dependent Mechanism. J Immunol 170: 1958-1963.
34. Siciliano NA, Skinner JA, Yuk MH, (2006) Bordetella bronchiseptica modulates macrophage phenotype leading to the inhibition of CD4+ T cell proliferation and the initiation of a Th17 immune response. J Immunol 177: 7131-7138.
35. Freitas A, Alves-Filho JC, Victoni T, Secher T, Lemos HP, et al. (2009) IL-17 receptor signaling is required to control polymicrobial sepsis. J Immunol 182: 7846-7854.
36. Miyamoto M, Prause O, Sjostrand M, Laan M, Lotvall J, et al. (2003) Endogenous IL-17 as a mediator of neutrophil recruitment caused by endotoxin exposure in mouse airways. J Immunol 170: 4665-4672.
37. Ye P, Garvey PB, Zhang P, Nelson S, Bagby G, et al. (2001) Interleukin-17 and lung host defense against Klebsiella pneumoniae infection. Am J Respir Cell Mol Biol 25: 335-340.
38. Happel KI, Zheng M, Young E, Quinton LJ, Lockhart E, et al. (2003) Cutting edge: roles of Toll-like receptor 4 and IL-23 in IL-17 expression in response to Klebsiella pneumoniae infection. J Immunol 170: 4432-4436.
39. McKenzie BS, Kastelein RA, Cua DJ, (2006) Understanding the IL-23-IL-17 immune pathway. Trends Immunol 27: 17-23.
40. Conti HR, Shen F, Nayyar N, Stocum E, Sun JN, et al. (2009) Th17 cells and IL-17 receptor signaling are essential for mucosal host defense against oral candidiasis. J Exp Med 206: 299-311.
41. Huang W, Na L, Fidel PL, Schwarzenberger P, (2004) Requirement of interleukin-17A for systemic anti-Candida albicans host defense in mice. J Infect Dis 190: 624-631.
42. Werner JL, Metz AE, Horn D, Schoeb TR, Hewitt MM, et al. (2009) Requisite role for the dectin-1 beta-glucan receptor in pulmonary defense against Aspergillus fumigatus. J Immunol 182: 4938-4946.
43. Rudner XL, Happel KI, Young EA, Shellito JE, (2007) Interleukin-23 (IL-23)-IL-17 cytokine axis in murine Pneumocystis carinii infection. Infect Immun 75: 3055-3061.
44. Zelante T, De Luca A, Bonifazi P, Montagnoli C, Bozza S, et al. (2007) IL-23 and the Th17 pathway promote inflammation and impair antifungal immune resistance. Eur J Immunol 37: 2695-2706.
45. Voelz K, Lammas DA, May RC, (2009) Cytokine signaling regulates the outcome of intracellular macrophage parasitism by Cryptococcus neoformans. Infect Immun.
46. Muller U, Stenzel W, Kohler G, Werner C, Polte T, et al. (2007) IL-13 Induces Disease-Promoting Type 2 Cytokines, Alternatively Activated Macrophages and Allergic Inflammation during Pulmonary Infection of Mice with Cryptococcus neoformans. J Immunol 179: 5367-5377.
47. Ye P, Rodriguez FH, Kanaly S, Stocking KL, Schurr J, et al. (2001) Requirement of interleukin 17 receptor signaling for lung CXC chemokine and granulocyte colony-stimulating factor expression, neutrophil recruitment, and host defense. J Exp Med 194: 519-527.
48. Lee YK, Turner H, Maynard CL, Oliver JR, Chen D, et al. (2009) Late developmental plasticity in the T helper 17 lineage. Immunity 30: 92-107.
49. Hardison SE, Wozniak KL, Kolls JK, Wormley FL Jr, (2010) Interleukin-17 Is Not Required for Classical Macrophage Activation in a Pulmonary Mouse Model of Cryptococcus neoformans Infection. Infect Immun 78: 5341-5351.
50. Romani L, Fallarino F, De Luca A, Montagnoli C, D'Angelo C, et al. (2008) Defective tryptophan catabolism underlies inflammation in mouse chronic granulomatous disease. Nature 451: 211-215.
51. Andreasen C, Powell DA, Carbonetti NH, (2009) Pertussis toxin stimulates IL-17 production in response to Bordetella pertussis infection in mice. PLoS ONE 4: e7079.
52. Hardison SE, Ravi S, Wozniak KL, Young ML, Olszewski MA, et al. (2010) Pulmonary infection with an interferon-gamma-producing Cryptococcus neoformans strain results in classical macrophage activation and protection. Am J Pathol 176: 774-785.
53. Cox GM, McDade HC, Chen SC, Tucker SC, Gottfredsson M, et al. (2001) Extracellular phospholipase activity is a virulence factor for Cryptococcus neoformans. Mol Microbiol 39: 166-175.
54. Cox GM, Mukherjee J, Cole GT, Casadevall A, Perfect JR, (2000) Urease as a virulence factor in experimental cryptococcosis. Infect Immun 68: 443-448.